
Sie befinden sich hier:
Publikationen
Ausgewählte Veröffentlichungen (ab 2001 nach Erscheinungsdatum):
Joussen AM, Doehmen S, Le ML, Koizumi K, Radetzky S, Krohne TU, Poulaki V, Semkova I, Kociok N. Mol Vis. 2009 Jul 25;15:1418-28.PMID: 19641635
Kociok N, Radetzky S, Krohne TU, Gavranic C, Liang Y, Semkova I, Joussen AM. Exp Eye Res. 2009 Oct;89(4):503-10. Epub 2009 May 29.PMID: 19482023
Joussen AM, Lux A, Kirchhof B. Br J Ophthalmol. 2009 Jan;93(1):128-9. PMID: 19098052
A cleaning solution for silicone intraocular lenses: "sticky silicone oil".
Liang Y, Kociok N, Leszczuk M, Hiebl W, Theisinger B, Lux A, Joussen AM.
Br J Ophthalmol. 2008 Nov;92(11):1522-7. Epub 2008 Aug 26.PMID: 18728053
The concept of heavy tamponades-chances and limitations.
Joussen AM, Wong D. Graefes Arch Clin Exp Ophthalmol. 2008 Sep;246(9):1217-24. Epub 2008 Jun 11. Review.PMID: 18546009
Pneumatic retinopexy by evaporation of fluorocarbon liquids: in vitro and in vivo results.
Mackiewicz J, Mühling B, Hiebl W, Meinert H, Kociok N, Joussen AM. Graefes Arch Clin Exp Ophthalmol. 2008 Jan;246(1):69-79. Epub 2007 Oct 10.PMID: 17926057
Maier AK, Kociok N, Zahn G, Vossmeyer D, Stragies R, Muether PS, Joussen AM.
Curr Eye Res. 2007 Sep;32(9):801-12.PMID: 17882713
The role of integrin alpha5beta1 in the regulation of corneal neovascularization.
Muether PS, Dell S, Kociok N, Zahn G, Stragies R, Vossmeyer D, Joussen AM.
Exp Eye Res. 2007 Sep;85(3):356-65. Epub 2007 Jun 15.PMID: 17659277
Joussen AM, Weiss C, Bauer D, Hilgers RD; TIME Study group. Graefes Arch Clin Exp Ophthalmol. 2007 Dec;245(12):1781-7. Epub 2007 Jul 26.PMID: 17653751
Heussen FM, Fawzy NF, Joeres S, Lux A, Maaijwee K, Meurs JC, Kirchhof B, Joussen AM.
Eye (Lond). 2008 Jun;22(6):799-807. Epub 2007 Jul 20.PMID: 17641681
Maaijwee K, Heimann H, Missotten T, Mulder P, Joussen A, van Meurs J. Graefes Arch Clin Exp Ophthalmol. 2007 Nov;245(11):1681-9. Epub 2007 Jun 12.PMID: 17562066
Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions.
Lux A, Llacer H, Heussen FM, Joussen AM. Br J Ophthalmol. 2007 Oct;91(10):1318-22. Epub 2007 May 30.PMID: 17537784
Joussen AM, Lehmacher W, Hilgers RD, Kirchhof B. Surv Ophthalmol. 2007 May-Jun;52(3):266-78. Review.PMID: 17472802
Joussen AM, Kirchhof B, Schrage N, Ocklenburg C, Hilgers RD; HSO Study Group. Acta Ophthalmol Scand. 2007 Sep;85(6):623-30. Epub 2007 Apr 4.PMID: 17408389
In vivo retinal tolerance of various heavy silicone oils.
Mackiewicz J, Mühling B, Hiebl W, Meinert H, Maaijwee K, Kociok N, Lüke C, Zagorski Z, Kirchhof B, Joussen AM. Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1873-83.PMID: 17389523
Joeres S, Llacer H, Heussen FM, Weiss C, Kirchhof B, Joussen AM. Eye (Lond). 2008 Jun;22(6):782-9. Epub 2007 Mar 2.PMID: 17332766
Joussen AM, Joeres S, Fawzy N, Heussen FM, Llacer H, van Meurs JC, Kirchhof B. Ophthalmology. 2007 Mar;114(3):551-60.PMID: 17324697
Joussen AM, Joeres S. Dev Ophthalmol. 2007;39:69-87. Review.PMID: 17245079
Pathophysiology of diabetic macular edema.
Joussen AM, Smyth N, Niessen C. Dev Ophthalmol. 2007;39:1-12. Review.PMID: 17245075
Kociok N, Radetzky S, Krohne TU, Gavranic C, Joussen AM. Invest Ophthalmol Vis Sci. 2006 Nov;47(11):5057-65.PMID: 17065527
Mackiewicz J, Maaijwee K, Lüke C, Kociok N, Hiebl W, Meinert H, Joussen AM. Graefes Arch Clin Exp Ophthalmol. 2007 May;245(5):665-75. Epub 2006 Oct 11.PMID: 17033791
Maaijwee KJ, van Meurs JC, Kirchhof B, Mooij CM, Fischer JH, Mackiewicz J, Kobuch K, Joussen AM. Br J Ophthalmol. 2007 Apr;91(4):546-50. Epub 2006 Sep 20.PMID: 16987900
Inhibition of TNF-alpha reduces laser-induced choroidal neovascularization.
Shi X, Semkova I, Müther PS, Dell S, Kociok N, Joussen AM. Exp Eye Res. 2006 Dec;83(6):1325-34. Epub 2006 Sep 7.PMID: 16959248
Joussen AM, Heussen FM, Joeres S, Llacer H, Prinz B, Rohrschneider K, Maaijwee KJ, van Meurs J, Kirchhof B. Am J Ophthalmol. 2006 Jul;142(1):17-30.PMID: 16815247
Overexpression of FasL in retinal pigment epithelial cells reduces choroidal neovascularization.
Semkova I, Fauser S, Lappas A, Smyth N, Kociok N, Kirchhof B, Paulsson M, Poulaki V, Joussen AM. FASEB J. 2006 Aug;20(10):1689-91. Epub 2006 Jun 28.PMID: 16807368
Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity.
Kociok N, Krohne TU, Poulaki V, Joussen AM. Graefes Arch Clin Exp Ophthalmol. 2007 Feb;245(2):258-66.PMID: 16741710
PVR as a complication of rhegmatogeneous retinal detachment: a solved problem?
Joeres S, Kirchhof B, Joussen AM. Br J Ophthalmol. 2006 Jun;90(6):796-7. No abstract available. PMID: 16714271
Dell S, Peters S, Müther P, Kociok N, Joussen AM. Invest Ophthalmol Vis Sci. 2006 May;47(5):1928-37.PMID: 16639000
Kociok N, Joussen AM. Graefes Arch Clin Exp Ophthalmol. 2007 Jan;245(1):101-13. Epub 2006 Apr 6.PMID: 16598467
Götte M, Bernfield M, Joussen AM. Curr Eye Res. 2005 Jun;30(6):417-22.PMID: 16020273
Influence on membrane-mediated cell activation by vesicles of silicone oil or perfluorohexyloctane.
Kociok N, Gavranic C, Kirchhof B, Joussen AM. Graefes Arch Clin Exp Ophthalmol. 2005 Apr;243(4):345-58. Epub 2004 Oct 27.PMID: 15864624
[Surgical treatment of diabetic retinopathy and maculopathy]
Joussen AM, Llacer H, Mazciewicz J, Kirchhof B. Ophthalmologe. 2004 Dec;101(12):1171-80. Review. German. PMID: 15592847
[Peripheral retinal degenerations--treatment recommendations]
Joussen AM, Kirchhof B. Ophthalmologe. 2004 Oct;101(10):1035-47; quiz 1048-9. German. PMID: 15365748
Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy.
Poulaki V, Joussen AM, Mitsiades N, Mitsiades CS, Iliaki EF, Adamis AP. Am J Pathol. 2004 Aug;165(2):457-69.PMID: 15277220
A central role for inflammation in the pathogenesis of diabetic retinopathy.
Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, Schraermeyer U, Kociok N, Fauser S, Kirchhof B, Kern TS, Adamis AP. FASEB J. 2004 Sep;18(12):1450-2. Epub 2004 Jul 1.PMID: 15231732
Radetzky S, Walter P, Fauser S, Koizumi K, Kirchhof B, Joussen AM. Graefes Arch Clin Exp Ophthalmol. 2004 Apr;242(4):273-8. Epub 2004 Mar 23.PMID: 15042375
Poulaki V, Mitsiades N, Kruse FE, Radetzky S, Iliaki E, Kirchhof B, Joussen AM. Am J Pathol. 2004 Apr;164(4):1293-302.PMID: 15039217
Cell transplantation in age related macular degeneration: current concepts and future hopes.
Joussen AM. Graefes Arch Clin Exp Ophthalmol. 2004 Jan;242(1):1-2. Epub 2003 Nov 14. PMID: 14745559
Koizumi K, Poulaki V, Doehmen S, Welsandt G, Radetzky S, Lappas A, Kociok N, Kirchhof B, Joussen AM. Invest Ophthalmol Vis Sci. 2003 May;44(5):2184-91.PMID: 12714660
VEGF-dependent conjunctivalization of the corneal surface.
Joussen AM, Poulaki V, Mitsiades N, Stechschulte SU, Kirchhof B, Dartt DA, Fong GH, Rudge J, Wiegand SJ, Yancopoulos GD, Adamis AP. Invest Ophthalmol Vis Sci. 2003 Jan;44(1):117-23.PMID: 12506063
Joussen AM, Poulaki V, Mitsiades N, Cai WY, Suzuma I, Pak J, Ju ST, Rook SL, Esser P, Mitsiades CS, Kirchhof B, Adamis AP, Aiello LP. FASEB J. 2003 Jan;17(1):76-8. Epub 2002 Nov 15.PMID: 12475915
Angiostatin inhibits and regresses corneal neovascularization.
Ambati BK, Joussen AM, Ambati J, Moromizato Y, Guha C, Javaherian K, Gillies S, O'Reilly MS, Adamis AP. Arch Ophthalmol. 2002 Aug;120(8):1063-8.PMID: 12149060
Suppression of diabetic retinopathy with angiopoietin-1.
Joussen AM, Poulaki V, Tsujikawa A, Qin W, Qaum T, Xu Q, Moromizato Y, Bursell SE, Wiegand SJ, Rudge J, Ioffe E, Yancopoulos GD, Adamis AP. Am J Pathol. 2002 May;160(5):1683-93.PMID: 12000720
Poulaki V, Qin W, Joussen AM, Hurlbut P, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP. J Clin Invest. 2002 Mar;109(6):805-15.PMID: 11901189
Joussen AM, Poulaki V, Qin W, Kirchhof B, Mitsiades N, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP. Am J Pathol. 2002 Feb;160(2):501-9.PMID: 11839570
Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression.
Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koizumi K, Döhmen S, Adamis AP. FASEB J. 2002 Mar;16(3):438-40. Epub 2002 Jan 30.PMID: 11821258
Vascular plasticity--the role of the angiopoietins in modulating ocular angiogenesis.
Joussen AM. Graefes Arch Clin Exp Ophthalmol. 2001 Dec;239(12):972-5. Review.PMID: 11820705
In vivo retinal gene expression in early diabetes.
Joussen AM, Huang S, Poulaki V, Camphausen K, Beecken WD, Kirchhof B, Adamis AP. Invest Ophthalmol Vis Sci. 2001 Nov;42(12):3047-57.PMID: 11687554
[Diabetic maculopathy. Etiological mechanisms and possible treatment approaches]
Joussen AM, Lemmen KD, Kirchhof B. Ophthalmologe. 2001 Sep;98(9):908-18; quiz 919, 921. Review. German. No abstract available. PMID: 11594237
Inhibition of inflammatory corneal angiogenesis by TNP-470.
Joussen AM, Beecken WD, Moromizato Y, Schwartz A, Kirchhof B, Poulaki V. Invest Ophthalmol Vis Sci. 2001 Oct;42(11):2510-6.PMID: 11581191
VEGF-initiated blood-retinal barrier breakdown in early diabetes.
Qaum T, Xu Q, Joussen AM, Clemens MW, Qin W, Miyamoto K, Hassessian H, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP. Invest Ophthalmol Vis Sci. 2001 Sep;42(10):2408-13.PMID: 11527957
Forschungsdatenbank
Für mehr Details nutzen Sie bitte auch die Forschungsdatenbank der Charité.